skip to Main Content

July 28, 2021
Illustrated Glossary for Long-Acting Technologies
Publication
The Illustrated Glossary for Long-Acting Technologies compiles frequent terms and concepts used in the research and development of long-acting technologies. The glossary is a non-exhaustive list and the graphics are artistic renderings meant to spur discussion and assist with community treatment literacy. 

July 27, 2021
Launch of Public Health Partnership to Tackle the Silent Epidemic of Hepatitis C in Low- and Middle-Income Countries
Statement / Press
The Drugs for Neglected Diseases initiative (DNDi), Médecins Sans Frontières (MSF), FIND, the global alliance for diagnostics, and the Treatment Action Group are joining forces to tackle a ‘silent’ public health injustice: the continuing disparities in access to diagnostics and treatment for the hepatitis C virus (HCV) in low- and…

July 16, 2021
2021 Pipeline Report
Pipeline Report
Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

June 24, 2021
Programmatic Communications Coordinator
Treatment Action Group is seeking an ambitious, experienced, creative, hands-on, and organized Coordinator for our Programmatic Communications. Seated in our communications team, this new position at TAG will support and amplify the work of our fast-moving and far-reaching policy and program teams.

June 21, 2021
Development & Grant Officer (Part-Time)
TAG is seeking a dynamic, highly motivated, and organized Development & Grant Officer to support grant and fundraising efforts.

June 16, 2021
Research in Action Awards 2021
Save the date for Tuesday, November 16, 2021! TAG’s 2021 Research in Action Awards will honor some of the best and brightest activists, scientists, and leaders in the fight to end HIV, tuberculosis, and hepatitis C across the U.S. and around the world. This year we’ll once again gather virtually…

June 7, 2021
Letter Demanding Unitaid Hepatitis Advocacy
Letter / Comment
Letter from TAG and other CSOs and NGOs to the Unitaid Executive Board demanding that Unitaid continue to invest in curing hepatitis C, and treating hepatitis B, as well as harm reduction.

June 4, 2021
2020 Annual Report
Publication
As the HIV epidemic changes over time, and new pandemics continue to emerge, TAG continues to evolve while remaining true to our activist roots. We partner with the most affected communities in the U.S. and around the world.

June 3, 2021
TAG Urges Governor to Sign New York State Bill Expanding Adult Vaccines Available in Pharmacies
Statement / Press
The bill, S4807A (Stavisky) / A6476A (Hyndman), improves preventive viral hepatitis vaccine access, and is particularly important for people who use drugs and unhoused New Yorkers.

May 10, 2021
Time for $5 Coalition Statement: Cepheid’s Updated GeneXpert Pricing Does Not Address Country Needs
Statement / Press
The Time for $5 Coalition, comprised of over 150 civil society organizations globally, calls out Cepheid for the company’s insufficient and self-serving GeneXpert pricing packages for low- and middle-income countries (LMICs), announced May 6, 2021.

Back To Top